Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP-001 following hepatic tumor ablation in metastatic colorectal cancer
NCT07321847Phase 3Not yet recruiting
- Sponsor
- Immunophotonics
- Start
- May 2026
- Primary completion
- Dec 2033
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of IP-001 in colorectal cancer (CRC), sponsored by Immunophotonics. Planned start May 2026; status: not yet recruiting.
02
Drugs
IP-001
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07321847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07321847.